The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 30, 2014

Filed:

Dec. 20, 2011
Applicants:

Joseph T. Bruder, Gaithersburg, MD (US);

Duncan Mcvey, Derwood, MD (US);

Douglas E. Brough, Gaithersburg, MD (US);

Inventors:

Joseph T. Bruder, Gaithersburg, MD (US);

Duncan McVey, Derwood, MD (US);

Douglas E. Brough, Gaithersburg, MD (US);

Assignee:

GenVec, Inc., Gaithersburg, MD (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); C07K 14/005 (2006.01); C12N 15/86 (2006.01); C12N 15/63 (2006.01); C07H 21/04 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); C12N 2810/6018 (2013.01); A61K 2039/5256 (2013.01); C07K 2319/00 (2013.01); C07K 14/005 (2013.01); C12N 2710/10322 (2013.01); C12N 2770/24134 (2013.01); C12N 2710/10345 (2013.01); C12N 2710/10343 (2013.01); C07K 2319/40 (2013.01); C12N 15/86 (2013.01);
Abstract

The invention relates to a replication-deficient adenoviral vector comprising two or more nucleic acid sequences encoding Dengue virus antigens and a chimeric hexon protein. The chimeric hexon protein comprises a first portion and a second portion. The first portion comprises at least 10 contiguous amino acid residues from a first adenovirus serotype (e.g., serotype 5 adenovirus hexon protein), optionally with one amino acid substitution. The second portion comprises (a) at least one hypervariable region (HVR) of a hexon protein of an adenovirus of a second adenovirus serotype, or (b) at least one synthetic hypervariable region (HVR) that is not present in the hexon protein of the wild-type adenovirus of the first adenovirus serotype.


Find Patent Forward Citations

Loading…